LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q2 EPS of ($0.13), $0.05 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $259.6 million versus the consensus estimate of $255.19 million.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.